Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JFIN
9376
PUT
Jiayin Group
JFIN
$116M
| $284K | ﹤0.01% |
41,200
+26,300
| +177% | +$151K |
|
9377
NeoGenomics
NEO
$2.08B
| $284K | ﹤0.01% |
+19,226
| New | +$301K |
|
9378
WisdomTree Voya Yield Enhanced USD Universal Bond Fund
UNIY
$1.31B
| $284K | ﹤0.01% |
5,661
-142,766
| -96% | -$7.07M |
|
9379
PUT
PLAYSTUDIOS Inc
MYPS
$61.9M
| $283K | ﹤0.01% |
+187,700
| New | +$330K |
|
9380
PUT
Archrock
AROC
$6.07B
| $283K | ﹤0.01% |
14,000
+700
| +5% | +$14.2K |
|
9381
CALL
Virco
VIRC
$93.6M
| $283K | ﹤0.01% |
20,500
+17,800
| +659% | +$271K |
|
9382
CALL
Denison Mines
DNN
$2.89B
| $283K | ﹤0.01% |
154,600
-69,700
| -31% | -$122K |
|
9383
CALL
Saratoga Investment
SAR
$301M
| $283K | ﹤0.01% |
12,200
+6,300
| +107% | +$145K |
|
|
DCBO
9384
CALL
Docebo
DCBO
$572M
| $283K | ﹤0.01% |
6,400
-400
| -6% | -$16.4K |
|
9385
CALL
Humacyte
HUMA
$156M
| $283K | ﹤0.01% |
52,000
+39,600
| +319% | +$261K |
|
9386
PUT
Avista
AVA
$3.27B
| $283K | ﹤0.01% |
7,300
-5,100
| -41% | -$193K |
|
9387
CALL
Moog Inc Class A
MOG.A
$14.1B
| $283K | ﹤0.01% |
1,400
+400
| +40% | +$75.2K |
|
9388
Invesco ESG NASDAQ 100 ETF
QQMG
$206M
| $282K | ﹤0.01% |
8,435
-25,946
| -75% | -$846K |
|
|
SWTX
9389
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $282K | ﹤0.01% |
8,800
+5,700
| +184% | +$213K |
|
9390
Global X Russell 2000 Covered Call ETF
RYLD
$1.4B
| $282K | ﹤0.01% |
+17,446
| New | +$279K |
|
9391
Passage Bio
PASG
$14.6M
| $282K | ﹤0.01% |
20,126
+12,213
| +154% | +$194K |
|
9392
CALL
Aura Biosciences
AURA
$796M
| $282K | ﹤0.01% |
31,600
+30,800
| +3,850% | +$264K |
|
9393
CALL
VinFast Auto
VFS
$7.3B
| $282K | ﹤0.01% |
73,700
+55,600
| +307% | +$220K |
|
9394
VanEck Vietnam ETF
VNM
$496M
| $281K | ﹤0.01% |
22,000
-10,334
| -32% | -$127K |
|
|
ADAM
9395
CALL
Adamas Trust
ADAM
$910M
| $281K | ﹤0.01% |
44,400
-10,000
| -18% | -$64.4K |
|
9396
CALL
BGC Group
BGC
$5.31B
| $281K | ﹤0.01% |
30,600
-50,800
| -62% | -$475K |
|
9397
PUT
Rayonier Advanced Materials
RYAM
$563M
| $281K | ﹤0.01% |
32,800
+17,500
| +114% | +$121K |
|
9398
Innovator US Equity Buffer ETF March
BMAR
$261M
| $280K | ﹤0.01% |
+6,222
| New | +$272K |
|
9399
CALL
Associated Banc-Corp
ASB
$6.05B
| $280K | ﹤0.01% |
13,000
+1,800
| +16% | +$39.1K |
|
9400
Veeco
VECO
$3.33B
| $280K | ﹤0.01% |
8,447
-97,005
| -92% | -$3.64M |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.